J&J's LifeScan Unit Is Target of FDA/California Attorney General Probe
This article was originally published in The Gray Sheet
Executive Summary
FDA and the California district attorney's office in San Francisco are investigating Johnson & Johnson LifeScan SureStep and SureStepPro blood glucose monitoring systems manufactured prior to July 1997.